Stefano Rusconi Selected Research

tipranavir

7/2009	Clinical validation and applicability of different tipranavir/ritonavir genotypic scores in HIV-1 protease inhibitor-experienced patients.
3/2004	Analysis of protease inhibitor combinations in vitro: activity of lopinavir, amprenavir and tipranavir against HIV type 1 wild-type and drug-resistant isolates.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Stefano Rusconi Research Topics

Disease

14	HIV Infections (HIV Infection) 09/2022 - 02/2003
13	Infections 10/2021 - 03/2004
10	COVID-19 01/2022 - 01/2020
7	Viremia 01/2021 - 03/2006
6	Coinfection 01/2020 - 10/2011
5	Acquired Immunodeficiency Syndrome (AIDS) 06/2021 - 02/2003
4	Pneumonia (Pneumonitis) 01/2021 - 01/2014
3	Disease Progression 01/2021 - 12/2011
3	Cardiovascular Diseases (Cardiovascular Disease) 11/2020 - 04/2017
3	Neoplasms (Cancer) 01/2017 - 12/2004
2	Liver Cirrhosis (Hepatic Cirrhosis) 01/2019 - 09/2014
2	Hyperbilirubinemia 01/2018 - 01/2017
2	Sepsis (Septicemia) 01/2017 - 01/2014
2	Dyslipidemias (Dyslipidemia) 01/2017 - 01/2017
2	Proteinuria 07/2014 - 05/2014
2	Glycosuria 07/2014 - 05/2014
1	Chronic Disease (Chronic Diseases) 09/2022
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2022
1	Syphilis 10/2021
1	Body Weight (Weight, Body) 06/2021
1	Mediastinal Emphysema (Pneumomediastinum) 01/2021
1	Insulin Resistance 01/2021
1	Respiratory Insufficiency (Respiratory Failure) 01/2021
1	Metabolic Bone Diseases (Osteopenia) 01/2021
1	Pneumothorax 01/2021
1	Type 2 Diabetes Mellitus (MODY) 12/2020
1	Obesity 01/2020
1	Hypertrophy 01/2020
1	Ganglion Cysts (Ganglion) 01/2018
1	Cognitive Dysfunction 01/2018
1	Lipodystrophy 01/2017
1	Hypercholesterolemia 01/2017
1	Hypertriglyceridemia 01/2017

Drug/Important Bio-Agent (IBA)

7	Protease Inhibitors (Protease Inhibitor)IBA 01/2017 - 03/2003
6	Pharmaceutical PreparationsIBA 12/2018 - 02/2003
4	RNA (Ribonucleic Acid)IBA 10/2021 - 01/2014
4	Darunavir (Prezista)FDA Link 01/2021 - 01/2019
3	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 03/2006
3	CytokinesIBA 01/2022 - 09/2005
3	dolutegravirIBA 06/2021 - 11/2020
3	abacavir (Ziagen)FDA Link 01/2019 - 01/2007
3	Maraviroc FDA Link 01/2019 - 01/2014
2	RacivirIBA 06/2021 - 10/2016
2	LipidsIBA 06/2021 - 01/2017
2	TabletsIBA 06/2021 - 04/2017
2	Lopinavir FDA Link 01/2021 - 03/2004
2	Atazanavir Sulfate (Reyataz)FDA Link 01/2021 - 01/2017
2	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 09/2014
2	Ritonavir (Norvir)FDA Link 01/2021 - 01/2019
2	Antiviral Agents (Antivirals)IBA 01/2020 - 04/2007
2	Raltegravir Potassium FDA Link 01/2019 - 01/2017
2	Nevirapine (Viramune)FDA Link 11/2018 - 01/2018
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 04/2017 - 01/2017
2	Illicit Drugs (Recreational Drugs)IBA 01/2017 - 01/2017
2	Integrase InhibitorsIBA 01/2017 - 01/2016
2	LDL CholesterolIBA 01/2017 - 09/2014
2	Triglycerides (Triacylglycerol)IBA 01/2017 - 01/2016
2	EnzymesIBA 01/2017 - 01/2017
2	HDL CholesterolIBA 01/2016 - 09/2014
2	Uric Acid (Urate)IBA 07/2014 - 05/2014
2	Phosphates (Orthophosphate)IBA 07/2014 - 05/2014
2	Peptide Hydrolases (Proteases)FDA Link 07/2009 - 03/2003
2	tipranavir FDA Link 07/2009 - 03/2004
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022
1	mRNA VaccinesIBA 01/2022
1	Interleukin-8 (Interleukin 8)IBA 12/2021
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 12/2021
1	Emtricitabine (Emtriva)FDA Link 06/2021
1	elvitegravirIBA 06/2021
1	tenofovir alafenamideIBA 06/2021
1	CholesterolIBA 06/2021
1	Lamivudine (Epivir)FDA Link 06/2021
1	Rilpivirine (TMC-278)IBA 06/2021
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2021
1	Toll-Like Receptor 7IBA 01/2021
1	Sitagliptin Phosphate (Januvia)FDA Link 12/2020
1	Oxygen (Dioxygen)IBA 12/2020
1	Dipeptidyl-Peptidase IV InhibitorsIBA 12/2020
1	Insulin (Novolin)FDA Link 12/2020
1	Biomarkers (Surrogate Marker)IBA 10/2020
1	Indicators and Reagents (Reagents)IBA 01/2020
1	CreatinineIBA 01/2020
1	C-Reactive ProteinIBA 01/2020
1	Phosphotransferases (Kinase)IBA 01/2020
1	remdesivirIBA 01/2020
1	DNA-Directed RNA Polymerases (RNA Polymerase)IBA 01/2019
1	lamivudine drug combination abacavir FDA Link 01/2019
1	BilirubinIBA 04/2018
1	Cytochrome P-450 CYP2B6 (CYP2B6)IBA 01/2018
1	Retinaldehyde (Retinal)IBA 01/2018
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 04/2017
1	Biological ProductsIBA 04/2017
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2017

Therapy/Procedure

15	Therapeutics 01/2021 - 12/2011
9	Highly Active Antiretroviral Therapy (HAART) 01/2020 - 02/2003
3	Art Therapy 09/2022 - 01/2021
1	Continuous Positive Airway Pressure 01/2021
1	Positive-Pressure Respiration (Positive End-Expiratory Pressure) 01/2021
1	Noninvasive Ventilation 01/2021
1	Artificial Respiration (Mechanical Ventilation) 01/2020